CELU earnings: next report 2026-08-12, real EPS beat/miss history, analyst consensus Buy, P/E -0.21. Updated 2026-07-23.
Celularity (CELU) Research Hub
Celularity (CELU) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 1.41 USD (-2.08%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.21, market cap 0.02B. This hub links to the full technical, earnings and options research available for CELU.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 1.41 USD (-2.08%) |
| 52-week range | 0.56 USD – 2.2 USD |
| Trend regime | Range |
| 14-day RSI | 71.4 (Overbought) |
| Trailing P/E | -0.21 |
| Market cap | 0.02B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-12 |
Available research for CELU
Covered Call on CELU: how it works, illustrative setup around the real 1.41 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on CELU: how it works, illustrative setup around the real 1.41 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on CELU: how it works, illustrative setup around the real 1.41 USD price, max profit/loss, breakeven and when to use it. Educational.
CELU technical analysis: range, last 1.41 USD, RSI 71.4, 52w range 0.56 USD–2.2 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is CELU in?
Celularity (CELU) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is CELU in an uptrend or downtrend?
As of 2026-09-11, CELU is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is CELU's trailing P/E ratio?
CELU's trailing P/E is -0.21, with a market cap of 0.02B. See the earnings research page for full valuation detail.
When does CELU next report earnings?
CELU is next scheduled to report earnings on 2026-08-12.